Sort   by:  
 Page size 
UnknownmTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development.
Not available
S-EPMC6407673 | biostudies-literature
UnknownNeuronal α-Synuclein Disease Stage Progression over 5 Years.
Not available
S-EPMC12273616 | biostudies-literature
UnknownLongitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease.
Not available
S-EPMC7098385 | biostudies-literature
UnknownThe Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.
Not available
S-EPMC6292383 | biostudies-literature
UnknownSARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.
Not available
S-EPMC8132231 | biostudies-literature
UnknownSARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.
Not available
S-EPMC8651551 | biostudies-literature
UnknownInhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations.
Not available
S-EPMC6506359 | biostudies-literature
UnknownHLA in isolated REM sleep behavior disorder and Lewy body dementia.
Not available
S-EPMC10502660 | biostudies-literature
UnknownDiagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.
Not available
S-EPMC4575273 | biostudies-literature
UnknownIntegrated multi-omics highlights alterations of gut microbiome functions in prodromal and idiopathic Parkinson's disease.
Not available
S-EPMC12502400 | biostudies-literature
Sort   by:  
 Page size